I-Flow Corporation 

(Public, NASDAQ:IFLO)   Watch this stock   
Find more results for IFLO
Nov 5, 2009
Q3 2009 Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 2.40% -22.92%
Operating margin 2.90% -26.28%
EBITD margin - -24.61%
Return on average assets 2.39% -18.08%
Return on average equity 3.06% -22.21%
Employees 1,100 -

Address

20202 Windrow Drive
Lake Forest, CA 92630
United States - Map
+1-949-2062700 (Phone)
+1-949-2062600 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

I-Flow Corporation discussions

  View all discussions »

Description

I-Flow Corporation (I-Flow) is engaged in designing, developing and marketing drug delivery systems and surgical products for post-surgical pain relief and surgical site care. The Company’s products are used in hospitals, free-standing surgery centers, homes and other settings. The Company’s flagship product line, ON-Q Pain Relief System (ON-Q), reduces the need for narcotics to relieve pain after surgery so patients get home faster. I-Flow manufactures and sells the ON-Q line of compact, portable infusion pumps, catheters and pain kits that automatically administer local anesthetic directly to or near the surgical site or near an adjacent nerve or nerve bundle. The Company also manufactures and sells a line of disposable infusion pumps used to administer chemotherapies, antibiotics and other medications. On February 15, 2008, the Company acquired AcryMed Incorporated (AcryMed).

Officers and directors

Donald M. Earhart
Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation - Reuters
James R. Talevich
Chief Financial Officer, Treasurer
Age: 58
Bio & Compensation - Reuters
James J. Dal Porto
Chief Operating Officer, Executive Vice President, Secretary, Director
Age: 56
Bio & Compensation - Reuters
Henry Tsutomu Tai M.D., Ph.D.
Director
Age: 66
Bio & Compensation - Reuters
John H. Abeles M.D.
Director
Age: 64
Bio & Compensation - Reuters
Jack H. Halperin Esq.
Director
Age: 62
Bio & Compensation - Reuters
Joel Stephen Kanter
Director
Age: 52
Bio & Compensation - Reuters
Erik H. Loudon
Director
Age: 70
Bio & Compensation - Reuters